Associations of Serum CIRP and CXCL5 With Prognosis and Neutrophil Extracellular Traps in Pediatric Mycoplasma pneumoniae Pneumonia
Litao Wan, Bolin Liu, Ning Xie, Jianhua Li, Ting Su, Liyan Zhang, Xiaohua Wang, Shiding Gao · 2026
Read Associations of Serum CIRP and CXCL5 With Prognosis and Neutrophil Extracellular Traps in Pediatric Mycoplasma pneumoniae Pneumonia by Litao Wan, Bolin Liu, Ning Xie, Jianhua Li, Ting Su, Liyan Zhang, Xiaohua Wang, Shiding Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13612372.txt.
Description
Litao Wan leads an eight-author team searching blood for early warnings in childhood Mycoplasma pneumonia. Most children recover, but some deteriorate, and clinicians lack sharp prognostic tools. The team enrolled 485 hospitalized children between January 2022 and March 2025 and split them by outcome one week after treatment. They measured two candidate proteins, CIRP and CXCL5, alongside markers of neutrophil extracellular traps.
Children with poor outcomes, 106 of them, ran longer fevers, showed more multilobar involvement and pleural effusion, and needed more rescue treatments. Their CIRP and CXCL5 levels were higher, and both proteins predicted poor prognosis in adjusted models. Alone each discriminated moderately; combined, the area under the curve reached 0.796. Both proteins also correlated with the trap markers MPO-DNA and citrullinated histone H3, hinting at a shared pathway. The authors propose the pair for early risk flagging, noting that causality through trap biology remains unproven.
Catalog record
| CREATOR | Litao Wan, Bolin Liu, Ning Xie, Jianhua Li, Ting Su, Liyan Zhang, Xiaohua Wang, Shiding Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |